Addex Therapeutics Ltd ADXN
ADXN
Addex Therapeutics Ltd CDIO
Cardio Diagnostics Holdings, Inc. BCLI
Brainstorm Cell Therapeutics Inc. MTNB
Matinas BioPharma Holdings, Inc. RADX
Radiopharm Theranostics Limited IBO
Impact BioMedical Inc. QNRX
Quoin Pharmaceuticals, Ltd. TCRT
Alaunos Therapeutics, Inc. NRSN
NeuroSense Therapeutics Ltd. NBY
NovaBay Pharmaceuticals, Inc.
Addex Therapeutics Ltd CDIO
Cardio Diagnostics Holdings, Inc. BCLI
Brainstorm Cell Therapeutics Inc. MTNB
Matinas BioPharma Holdings, Inc. RADX
Radiopharm Theranostics Limited IBO
Impact BioMedical Inc. QNRX
Quoin Pharmaceuticals, Ltd. TCRT
Alaunos Therapeutics, Inc. NRSN
NeuroSense Therapeutics Ltd. NBY
NovaBay Pharmaceuticals, Inc.
Performance
| Periode | ADXN | CDIO | BCLI | MTNB | RADX | IBO | QNRX | TCRT | NRSN | NBY |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -7.45 % | -12.94 % | -54.10 % | -20.55 % | 15.08 % | 79.26 % | 63.22 % | -17.02 % | -65.53 % | 829.82 % |
| YTD | 3.85 % | -87.68 % | -73.83 % | 23.35 % | 11.85 % | -57.85 % | -39.63 % | 80.71 % | -29.57 % | 741.27 % |
| 1Y | -0.89 % | -88.94 % | -75.44 % | 33.08 % | 18.22 % | -44.04 % | -28.71 % | 81.63 % | -40.44 % | 900.00 % |
| 3Y | -35.61 % | -88.67 % | -97.95 % | -97.21 % | -70.63 % | -75.78 % | -97.73 % | -96.15 % | -42.55 % | -89.41 % |
| 5Y | -96.87 % | -98.90 % | -99.28 % | -98.61 % | -70.63 % | -75.78 % | -99.97 % | -99.15 % | -79.95 % | -99.31 % |
| 10Y | -96.54 % | -98.90 % | -98.65 % | -98.09 % | -70.63 % | -75.78 % | -100.00 % | -99.71 % | -79.95 % | -99.88 % |
| From the beginning | -96.54 % | -98.90 % | -77.87 % | -98.88 % | -70.63 % | -75.78 % | -100.00 % | -99.85 % | -79.95 % | -100.00 % |